» Articles » PMID: 27237592

Executive Summary of the SEPAR Recommendations for the Diagnosis and Treatment of Non-small Cell Lung Cancer

Abstract

The Thoracic Surgery and Thoracic Oncology groups of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) have backed the publication of a handbook on recommendations for the diagnosis and treatment of non-small cell lung cancer. Due to the high incidence and mortality of this disease, the best scientific evidence must be constantly updated and made available for consultation by healthcare professionals. To draw up these recommendations, we called on a wide-ranging group of experts from the different specialties, who have prepared a comprehensive review, divided into 4 main sections. The first addresses disease prevention and screening, including risk factors, the role of smoking cessation, and screening programs for early diagnosis. The second section analyzes clinical presentation, imaging studies, and surgical risk, including cardiological risk and the evaluation of respiratory function. The third section addresses cytohistological confirmation and staging studies, and scrutinizes the TNM and histological classifications, non-invasive and minimally invasive sampling methods, and surgical techniques for diagnosis and staging. The fourth and final section looks at different therapeutic aspects, such as the role of surgery, chemotherapy, radiation therapy, a multidisciplinary approach according to disease stage, and other specifically targeted treatments, concluding with recommendations on the follow-up of lung cancer patients and surgical and endoscopic palliative interventions in advanced stages.

Citing Articles

Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards.

Zabaleta J, Aguinagalde B, Lopez I, Fernandez-Monge A, Lizarbe J, Mainer M J Clin Med. 2025; 14(2).

PMID: 39860405 PMC: 11765867. DOI: 10.3390/jcm14020399.


Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers.

Cordoba-Lanus E, Montuenga L, Dominguez-de-Barros A, Oliva A, Mayato D, Remirez-Sanz A Antioxidants (Basel). 2024; 13(2).

PMID: 38397754 PMC: 10886051. DOI: 10.3390/antiox13020156.


[Questions and Answers in Lung Cancer].

Manzano C, Fuentes-Martin A, Zuil M, Gil Barturen M, Gonzalez J, Cilleruelo-Ramos A Open Respir Arch. 2023; 5(3):100264.

PMID: 37727151 PMC: 10505677. DOI: 10.1016/j.opresp.2023.100264.


Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.

Cordoba-Lanus E, Dominguez de-Barros A, Oliva A, Mayato D, Gonzalvo F, Remirez-Sanz A Int J Mol Sci. 2023; 24(15).

PMID: 37569812 PMC: 10418760. DOI: 10.3390/ijms241512437.


Beneficial Effects of Resveratrol in Mouse Gastrocnemius: A Hint to Muscle Phenotype and Proteolysis.

Manas-Garcia L, Denhard C, Mateu J, Duran X, Gea J, Barreiro E Cells. 2021; 10(9).

PMID: 34572085 PMC: 8469306. DOI: 10.3390/cells10092436.